{'fraction_non_alphanumeric': 0.017828200972447326, 'fraction_numerical': 0.012965964343598054, 'mean_word_length': 4.885714285714286, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical Evaluation of an Epinephrine Suspension in the Treatment of Asthma

This study was carried out with 50 asthmatic children to evaluate the speed of action of Sus-Phrine,‡ which is epinephrine in a concentration of 1: 200, of which approximately 20 per cent is in solution for an immediate effect with the remainder in suspension for sustained action. The data indicated that Sus-Phrine is comparable to aqueous epinephrine in the rapidity of its bron chodilating effect. Because of its well-established prolonged action, this may be the drug of choice for the initial injection of epinephrine in acute asthma.